SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950116-01-000449
Filing Date
2001-03-19
Accepted
2001-03-19 00:00:00
Documents
2
Period of Report
2001-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q 0001.txt 10-Q 60633
2 FINANCIAL DATA SCHEDULE 0002.txt EX-27 2183
  Complete submission text file 0000950116-01-000449.txt   64366
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 1572016
SIC: 2834 Pharmaceutical Preparations